Effects of GSK3β/eEF2K signaling pathway on pulmonary fibrosis in mice.
10.12047/j.cjap.6201.2022.006
- Author:
Chao-Qun QIN
1
;
Bin HUANG
1
;
Fang YANG
1
;
Chang-Ming WANG
1
;
Ying XIAO
1
;
Yan-Ju MO
1
;
Yi LIAO
1
;
Feng GAO
1
Author Information
1. Guilin People's Hospital, Guilin 541002, China.
- Publication Type:Journal Article
- Keywords:
GSK3β/eEF2K;
MMP-2;
TDZD-8;
mice;
pulmonary fibrosis
- MeSH:
Animals;
Collagen;
Collagen Type I;
Elongation Factor 2 Kinase/metabolism*;
Eukaryota/metabolism*;
Fibrosis;
Glycogen Synthase Kinase 3 beta;
Male;
Matrix Metalloproteinase 2/metabolism*;
Mice;
Mice, Inbred C57BL;
Pulmonary Fibrosis/chemically induced*;
Signal Transduction
- From:
Chinese Journal of Applied Physiology
2022;38(1):32-36
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effects of glycogen synthase kinase-3β (GSK3β)/eukaryotic extension factor kinase 2 (eEF2K) signaling pathway on the process of pulmonary fibrosis through in vivo experiments, and find new ideas for clinical treatment of pulmonary fibrosis. Methods: The pulmonary fibrosis model of C57BL/6 male mice was induced by bleomycin with intratracheal injection at the dose of 2 mg/kg. After 14 days of modeling, animals were divided into model group, negative inhibition group and inhibition group (n=5 for each group), and control group was not processed. The inhibition group was treated with TDZD-8 (4 mg/kg) after modeling, the negative inhibition group was given DMSO solution after modeling, and the samples were collected after 28 days. Hematoxylin-eosin staining method was used to detect lung fibrosis in mice and scored according to Ashcroft scale. Expression levels of GSK3β, p-GSK3β, eEF2K, p-eEF2K (Ser70, Ser392, Ser470), precursor protein of matrix metalloproteinase-2 (pro-MMP-2), matrix metalloproteinase-2 (MMP-2), collagen I (Col I), collagen Ⅲ (Col Ⅲ) and α-smooth muscle actin (α-SMA) were detected by Western blot. Results: Compared with control group, the fibrosis score was up-regulated, the expression levels of GSK3β, p-GSK3β, p-eEF2K (Ser70, Ser392, Ser470), pro-MMP-2, MMP-2, Col I, Col Ⅲ and α-SMA were increased, while that of eEF2K was decreased in model group (P＜0.05). Compared with model group, the fibrosis score, expression levels of GSK3β, p-GSK3β, p-eEF2K (Ser70, Ser392, Ser470), pro-MMP-2, MMP-2, Col I, Col Ⅲ and α-SMA were decreased, but the expression level of eEF2K was increased in inhibition group (P＜0.05). Conclusion: GSK3β can activate eEF2K by phosphorylation at the sites of Ser70, Ser392 and Ser470, increase the contents of fibrosis indicators, promote the formation of pulmonary fibrosis, and aggravate lung tissue lesions.
